FDA criticized by congress, page-10

Mesoblast need to seriously consider going on the offensive with the FDA, enough fluffing around and extending trust there's simply too much invested and a significant amount to jeopardize considering big pharma will make every play to muddy the waters, hinder progress and attempt to manipulate FDA's thinking. No matter how large the financial reward is going on your own and thinking a couple of ex FDA employees will make the difference is not reassuring. Mesoblast needs a leading large pharmaceutical to do some of the heavy lifting that is required throughout 2023, Mediation and negotiation 101 comes down to what one party is prepared to give up to get their primary goal successful and partnership with a leading large pharmaceutical is essential now and being prepared to give some of the potential glory up before it is forced upon you.